Quanta Services Inc. Stock Rallies 5.1%, Outperforms Peers
Dow Jones2026/09/11 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Quanta Services Inc. rallied 5.1% to $650.58 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.9% to 7,656.98 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.
The stock's rise snapped a two-day losing streak.
Quanta Services Inc. closed 17.5% short of its 52-week high of $788.75, which the company reached on May 6th.
The stock outperformed some of its peers, as AECOM rose 1.0% to $63.53, MasTec Inc. rose 3.5% to $240.41, and EMCOR Group Inc. rose 4.32% to $780.66.
Trading volume totaled 940,291, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 11, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).